Comparable effectiveness using flexible single-dose GnRH antagonist (cetrorelix) and single-dose long GnRH agonist (goserelin) protocol for IVF cycles – a prospective, randomized study

Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin

Carola Albano, R. Felberbaum, Johan Smitz et al. · Human Reproduction · 2000 · 312 citations · Full text

Veterinary Medicine, Endocrinology, Gynecology +13

Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation

K. Diedrich, C. Diedrich, Eduarda M. Santos et al. · Human Reproduction · 1994 · 310 citations

Medicine, Endocrinology, Gynecology +17

A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon). The ganirelix dose-finding study group

Human Reproduction · 1998 · 293 citations · Full text

Pharmacy, Endocrinology, Pharmacology +17

Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin)

F. Olivennes, J. Belaïsch-Allart, Jean-Claude Emperaire et al. · Fertility and Sterility · 2000 · 257 citations · Full text

Veterinary Medicine, Obstetrics, Pharmacology +17

Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation

Carola Albano, Johan Smitz, Michel Camus et al. · Fertility and Sterility · 1997 · 243 citations · Full text

Medicine, Endocrinology, Gynecology +11